Defense of Lanham Act False Advertising Litigation
We represented a pharmaceutical compounding company in defense of Lanham Act false advertising litigation. We obtained dismissal for our client and denial of preliminary injunction motion.
We use cookies on this website to enhance user experience, analyze traffic, and for other purposes. By clicking accept, you consent to our use of cookies on this site. To learn more about cookies and how we use them, please review our Privacy Policy.
Necessary Cookies
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytical Cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.
